Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Oct;12(10):2804-19.
doi: 10.1074/mcp.M112.025882. Epub 2013 Jul 3.

Bcl2-associated athanogene 3 interactome analysis reveals a new role in modulating proteasome activity

Ying Chen  1 , Li-Na Yang, Li Cheng, Shun Tu, Shu-Juan Guo, Huang-Ying Le, Qian Xiong, Ran Mo, Chong-Yang Li, Jun-Seop Jeong, Lizhi Jiang, Seth Blackshaw, Li-Jun Bi, Heng Zhu, Sheng-Ce Tao, Feng Ge
Affiliations

Bcl2-associated athanogene 3 interactome analysis reveals a new role in modulating proteasome activity

Ying Chen et al. Mol Cell Proteomics. 2013 Oct.

Abstract

Bcl2-associated athanogene 3 (BAG3), a member of the BAG family of co-chaperones, plays a critical role in regulating apoptosis, development, cell motility, autophagy, and tumor metastasis and in mediating cell adaptive responses to stressful stimuli. BAG3 carries a BAG domain, a WW domain, and a proline-rich repeat (PXXP), all of which mediate binding to different partners. To elucidate BAG3's interaction network at the molecular level, we employed quantitative immunoprecipitation combined with knockdown and human proteome microarrays to comprehensively profile the BAG3 interactome in humans. We identified a total of 382 BAG3-interacting proteins with diverse functions, including transferase activity, nucleic acid binding, transcription factors, proteases, and chaperones, suggesting that BAG3 is a critical regulator of diverse cellular functions. In addition, we characterized interactions between BAG3 and some of its newly identified partners in greater detail. In particular, bioinformatic analysis revealed that the BAG3 interactome is strongly enriched in proteins functioning within the proteasome-ubiquitination process and that compose the proteasome complex itself, suggesting that a critical biological function of BAG3 is associated with the proteasome. Functional studies demonstrated that BAG3 indeed interacts with the proteasome and modulates its activity, sustaining cell survival and underlying resistance to therapy through the down-modulation of apoptosis. Taken as a whole, this study expands our knowledge of the BAG3 interactome, provides a valuable resource for understanding how BAG3 affects different cellular functions, and demonstrates that biologically relevant data can be harvested using this kind of integrated approach.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Identification of BAG3 interacting proteins with QUICK. A, overall workflow of the QUICK method. B, expression of BAG isoforms in BAG3 knockdown HeLa cells (siBAG3) and negative control cells (siNC). Relative to control cells, BAG3 knockdown HeLa cells showed diminished BAG3 protein levels, as expected. Depletion of BAG3 showed no obvious effect on the expression of the other BAG isoforms. Actin blotting was performed to ensure equal loading.
Fig. 2.
Fig. 2.
Identification of BAG3 interacting proteins with a human proteome microarray. A, workflow of the proteome microarray strategy for the identification of protein–protein interactions. B, human proteome microarrays were probed with BAG3 (left), followed by a BAG3 antibody and a Cy5-labeled secondary antibody. A control experiment was carried out without BAG3 (right). Many stronger signals can be observed from the microarray with BAG3 than from the microarray without BAG3. Enlarged areas from the same locations of the two micorarrays with and without BAG3 are illustrated in the middle. When the signals from the two microarrays were compared, 289 candidate BAG3 interacting proteins were identified. C, representative BAG3 interacting proteins.
Fig. 3.
Fig. 3.
Comparison of BAG3 interacting proteins identified via the QUICK and proteome microarray methods. A, Venn diagrams showing the degree of overlap between the QUICK and proteome microarray data sets. B, functional diversity among proteins present in two datasets. The relative distribution of all proteins from Homo sapiens, annotated according to the PANTHER functional classes, is shown by the line labeled “Expected.” This denotes the relative fraction (coverage) of all human proteins that belong to a given category. Deviations of the QUICK and proteome microarray datasets from this distribution are shown by different colored bars; for example, proteins labeled “transcription factor” are relatively underrepresented in the two datasets.
Fig. 4.
Fig. 4.
Protein interaction network of the BAG3 interactome. A, the complete BAG3 interaction network obtained from STRING with a confidence score greater than 0.4. The network contains 283 nodes and 2,863 edges. B–E, the four top-ranked and tightly connected network clusters obtained with MCODE are color-coded and rendered as separate modules.
Fig. 5.
Fig. 5.
Validation of newly identified BAG3 interactors by co-immunoprecipitation. Immunoprecipitation assays of 14-3–3ζ, ATG3, Hsp70, PSMB1, MAPK7, HSF1, and BAG3 proteins were carried out as described under “Experimental Procedures.” A, immunoblotting demonstrated that BAG3 protein binds with 14-3–3ζ, ATG3, PSMB1, MAPK7, HSF1, and Hsp70 proteins. No BAG3-interacting bands were observed in the negative control (IgG). “Input” stands for the total cell lysate extracted from HeLa cells. Similarly, reverse immunoprecipitation assays confirmed the binding of (B) 14-3–3ζ, (C) ATG3, (D) PSMB1, (E) Hsp70, (F) MAPK7, and (G) HSF1 protein with BAG3.
Fig. 6.
Fig. 6.
The effect of knockdown of BAG3 on proteasome activity and MG-132 sensitivity in HeLa cells. A, knockdown of BAG3 in HeLa cells was confirmed by Western blotting. B, quantitative analysis of BAG3 knockdown on apoptosis in HeLa cells. Data are expressed as the mean ± S.D. of the fractions of apoptotic cells from at least three experiments. C, knockdown of BAG3 resulted in a marked decrease in proteasome activity. D, knockdown of BAG3 increased the ubiquitin-tagged proteins in HeLa cells. Western blotting was carried out with anti-ubiquitin antibody using total cell lysates extracted from HeLa cells. Actin served as a loading control. Effect of knockdown of BAG3 on the chymotryptic, tryptic, and caspase-like activities of the (E) 26S or (F) 20S proteasome in HeLa cells, as measured using fluorogenic substrates. Experiments were repeated a minimum of three times. *p < 0.05 when compared with the control group. 1: untreated HeLa cells; 2: HeLa cells treated with control siRNA; 3: HeLa cells treated with BAG3 siRNA; 4: HeLa cells treated with MG-132; 5: HeLa cells treated with control siRNA and MG-132; 6: HeLa cells treated with BAG3 siRNA and MG-132.
Fig. 7.
Fig. 7.
The effect of overexpression of BAG3 on proteasome activity and MG-132 sensitivity in HeLa cells. A, overexpression of BAG3 in HeLa cells was confirmed by Western blotting. B, overexpression of BAG3 reduces MG-132 sensitivity in HeLa cells. C, overexpression of BAG3 resulted in a marked increase in proteasome activity in MG-132-treated cells. D, overexpression of BAG3 decreased the ubiquitin-tagged proteins in MG-132-treated HeLa cells. Effect of overexpression of BAG3 on the chymotryptic, tryptic, and caspase-like activities of the (E) 26S or (F) 20S proteasome in HeLa cells, as measured using fluorogenic substrates. Experiments were repeated a minimum of three times. *p < 0.05 when compared with the control group. 1: untreated HeLa cells; 2: HeLa cells treated with blank vector; 3: HeLa cells treated with BAG3 plasmid; 4: HeLa cells treated with MG-132; 5: HeLa cells treated with blank vector and MG-132; 6: HeLa cells treated with BAG3 plasmid and MG-132.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

  • BAG3 down-modulation sensitizes HPV18(+) HeLa cells to PEITC-induced apoptosis and restores p53.
    Cotugno R, Basile A, Romano E, Gallotta D, Belisario MA. Cotugno R, et al. Cancer Lett. 2014 Nov 28;354(2):263-71. doi: 10.1016/j.canlet.2014.08.022. Epub 2014 Aug 28. Cancer Lett. 2014. PMID: 25175321 Free PMC article.
  • Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease.
    Escott-Price V, Bellenguez C, Wang LS, Choi SH, Harold D, Jones L, Holmans P, Gerrish A, Vedernikov A, Richards A, DeStefano AL, Lambert JC, Ibrahim-Verbaas CA, Naj AC, Sims R, Jun G, Bis JC, Beecham GW, Grenier-Boley B, Russo G, Thornton-Wells TA, Denning N, Smith AV, Chouraki V, Thomas C, Ikram MA, Zelenika D, Vardarajan BN, Kamatani Y, Lin CF, Schmidt H, Kunkle B, Dunstan ML, Vronskaya M; United Kingdom Brain Expression Consortium; Johnson AD, Ruiz A, Bihoreau MT, Reitz C, Pasquier F, Hollingworth P, Hanon O, Fitzpatrick AL, Buxbaum JD, Campion D, Crane PK, Baldwin C, Becker T, Gudnason V, Cruchaga C, Craig D, Amin N, Berr C, Lopez OL, De Jager PL, Deramecourt V, Johnston JA, Evans D, Lovestone S, Letenneur L, Hernández I, Rubinsztein DC, Eiriksdottir G, Sleegers K, Goate AM, Fiévet N, Huentelman MJ, Gill M, Brown K, Kamboh MI, Keller L, Barberger-Gateau P, McGuinness B, Larson EB, Myers AJ, Dufouil C, Todd S, Wallon D, Love S, Rogaeva E, Gallacher J, George-Hyslop PS, Clarimon J, Lleo A, Bayer A, Tsuang DW, Yu L, Tsolaki M, Bossù P, Spalletta G, Proitsi P, Collinge J, Sorbi S, Garcia FS, Fox NC, Hardy J, Naranjo MC, Bosco P, Clarke R, Brayne C, Galimberti D, Scarpini E, Bonucc… See abstract for full author list ➔ Escott-Price V, et al. PLoS One. 2014 Jun 12;9(6):e94661. doi: 10.1371/journal.pone.0094661. eCollection 2014. PLoS One. 2014. PMID: 24922517 Free PMC article.
  • Classification of Homo sapiens gene behavior using linear discriminant analysis fused with minimum entropy mapping.
    Das J, Barman Mandal S. Das J, et al. Med Biol Eng Comput. 2021 Mar;59(3):673-691. doi: 10.1007/s11517-021-02324-y. Epub 2021 Feb 17. Med Biol Eng Comput. 2021. PMID: 33595791
  • Hsp70-Bag3 interactions regulate cancer-related signaling networks.
    Colvin TA, Gabai VL, Gong J, Calderwood SK, Li H, Gummuluru S, Matchuk ON, Smirnova SG, Orlova NV, Zamulaeva IA, Garcia-Marcos M, Li X, Young ZT, Rauch JN, Gestwicki JE, Takayama S, Sherman MY. Colvin TA, et al. Cancer Res. 2014 Sep 1;74(17):4731-40. doi: 10.1158/0008-5472.CAN-14-0747. Epub 2014 Jul 3. Cancer Res. 2014. PMID: 24994713 Free PMC article.
  • Current Experimental Methods for Characterizing Protein-Protein Interactions.
    Zhou M, Li Q, Wang R. Zhou M, et al. ChemMedChem. 2016 Apr 19;11(8):738-56. doi: 10.1002/cmdc.201500495. Epub 2016 Feb 11. ChemMedChem. 2016. PMID: 26864455 Free PMC article. Review.
See all "Cited by" articles

References

    1. Doong H., Vrailas A., Kohn E. C. (2002) What's in the “BAG”?—a functional domain analysis of the BAG-family proteins. Cancer Lett. 188, 25–32 - PubMed
    1. Kabbage M., Dickman M. B. (2008) The BAG proteins: a ubiquitous family of chaperone regulators. Cell. Mol. Life Sci. 65, 1390–1402 - PMC - PubMed
    1. Rosati A., Graziano V., De Laurenzi V., Pascale M., Turco M. C. (2011) BAG3: a multifaceted protein that regulates major cell pathways. Cell Death Dis. 2, e141. - PMC - PubMed
    1. Doong H., Rizzo K., Fang S., Kulpa V., Weissman A. M., Kohn E. C. (2003) CAIR-1/BAG-3 abrogates heat shock protein-70 chaperone complex-mediated protein degradation: accumulation of poly-ubiquitinated Hsp90 client proteins. J. Biol. Chem. 278, 28490–28500 - PubMed
    1. Hishiya A., Kitazawa T., Takayama S. (2010) BAG3 and Hsc70 interact with actin capping protein CapZ to maintain myofibrillar integrity under mechanical stress. Circ. Res. 107, 1220–1231 - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources